• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

dievini Hopp Biotech Holding

edit

dievini Hopp BioTech holding GmbH & Co. KG is a company dedicated to the support and coaching in the life cycle management of companies and organizations in Life and Health Sciences. A team of experts in medicine, science, finance, legal and entrepreneurship is in charge of accompanying investors, management and enterprises.

Recent Milestones

edit

• 
  dievini Hopp Biotech Holding invested in CureVac. (9/18/12)
  Posted 9/18/12 at 2:14am via prnewswire.com
• 
  dievini Hopp Biotech Holding invested in Apogenix. (2/28/12)
  Posted 2/28/12 at 5:15am via onbiovc.com
• 
  dievini Hopp Biotech Holding invested in immatics biotechnologies. (9/21/10)
  Posted 9/21/10 at 6:36am via immatics.com
• 
  dievini Hopp Biotech Holding invested in CureVac. (5/10/10)
  Posted 5/10/10 at 5:12pm via onbiovc.com

Investments

Videos

Sources

1. CureVac Secures EUR80 Million in Series D Financing (prnewswire.com) [edit]
2. Apogenix, GmbH: Series C $10M (onbiovc.com) [edit]
3. immatics raises €54 million to advance its late stage clinical therapeutic cancer vaccine portfolio (immatics.com) [edit]
4. CureVac, GmbH: Series C $34.9M (onbiovc.com) [edit]